← Eichor
Condition: Sjogrens Disease Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sjogrens Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CONTROLLED STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450 µG/ML RE
Phase 2 · 6 location(s) · Lubris Bio Pty Ltd · NCT07118241The Pathogenesis and Natural History of Sjogren's Disease
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT01425892OM336 in Seropositive Autoimmune Diseases
Phase 1 · 1 location(s) · Lakefront Biotherapeutics West LLC · NCT07229144AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Stud
Phase 2 · 52 location(s) · Artiva Biotherapeutics, Inc. · NCT06991114
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.